Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Rating of “Buy” from Analysts
Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) have earned an average recommendation of “Buy” from the fourteen brokerages that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and two have issued a strong buy recommendation on […]
Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) have earned an average recommendation of “Buy” from the fourteen brokerages that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and two have issued a strong buy recommendation on […]
